Michelle Lai

6.5k total citations · 3 hit papers
54 papers, 2.8k citations indexed

About

Michelle Lai is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michelle Lai has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 36 papers in Hepatology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michelle Lai's work include Liver Disease Diagnosis and Treatment (45 papers), Liver Disease and Transplantation (26 papers) and Liver Diseases and Immunity (12 papers). Michelle Lai is often cited by papers focused on Liver Disease Diagnosis and Treatment (45 papers), Liver Disease and Transplantation (26 papers) and Liver Diseases and Immunity (12 papers). Michelle Lai collaborates with scholars based in United States, Switzerland and Netherlands. Michelle Lai's co-authors include Nezam H. Afdhal, Elliot B. Tapper, Imad Nasser, Michael P. Curry, Benjamin J. Hyatt, Jay H. Hoofnagle, Robert S. Brown, Mark W. Russo, Mitchell L. Shiffman and James E. Everhart and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Michelle Lai

54 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

2021 261 citations Mazen Noureddin, Michelle Lai et al. Hepatology profile →
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

2018 257 citations Rohit Loomba, Zeid Kayali et al. Gastroenterology profile →
Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis

2020 228 citations Ping An, Linlin Wei et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Lai United States	23	2.1k	1.5k	712	631	435	54	2.8k
Julia C. Iezzoni United States	22	1.9k 0.9×	945 0.6×	578 0.8×	774 1.2×	515 1.2×	43	2.8k
Hironori Mawatari Japan	24	2.0k 1.0×	994 0.7×	449 0.6×	763 1.2×	319 0.7×	51	2.5k
David Ka‐Wai Yeung Hong Kong	19	2.1k 1.0×	733 0.5×	385 0.5×	933 1.5×	572 1.3×	21	2.6k
Veeral Ajmera United States	28	2.5k 1.2×	1.2k 0.8×	358 0.5×	893 1.4×	425 1.0×	70	3.0k
Indra Neil Guha United Kingdom	34	3.8k 1.8×	2.9k 1.9×	851 1.2×	809 1.3×	287 0.7×	112	4.6k
Joel Z. Stengel United States	5	1.6k 0.8×	702 0.5×	299 0.4×	688 1.1×	211 0.5×	6	1.9k
Nila Rafiq United States	16	2.8k 1.4×	1.4k 0.9×	491 0.7×	1.3k 2.0×	233 0.5×	26	3.1k
Meena B. Bansal United States	24	1.6k 0.8×	1.2k 0.8×	379 0.5×	494 0.8×	338 0.8×	73	2.5k
Jessica Dyson United Kingdom	23	1.8k 0.9×	1.7k 1.1×	890 1.3×	308 0.5×	205 0.5×	67	2.6k
Kittichai Promrat United States	16	2.4k 1.1×	1.2k 0.8×	340 0.5×	1.1k 1.8×	408 0.9×	34	2.8k

Countries citing papers authored by Michelle Lai

Since Specialization

Citations

This map shows the geographic impact of Michelle Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Lai more than expected).

Fields of papers citing papers by Michelle Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Lai. The network helps show where Michelle Lai may publish in the future.

Co-authorship network of co-authors of Michelle Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Lai. A scholar is included among the top collaborators of Michelle Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Lai. Michelle Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jixue, Li Cai, Jiang Zhao, et al.. (2025). A clinical study exploring the prediction of microvascular invasion in hepatocellular carcinoma through the use of combined enhanced CT and MRI radiomics. PLoS ONE. 20(1). e0318232–e0318232. 1 indexed citations

Zhang, Xinyuan, Longgang Zhao, Long Ngo, et al.. (2024). Prediagnostic plasma proteomics profile for hepatocellular carcinoma. JNCI Journal of the National Cancer Institute. 116(8). 1343–1355. 3 indexed citations

Amjad, Waseem, Irina Shalaurova, Erwin Garcia, et al.. (2023). Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences. 24(17). 13332–13332. 6 indexed citations

Long, Lu, Xing Liu, Jessica L. Petrick, et al.. (2023). Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality. JNCI Cancer Spectrum. 7(2). 10 indexed citations

Hakim, Aaron, Aimée M. Deaton, Lucas D. Ward, et al.. (2023). Advancing diagnosis and management of liver disease in adults through exome sequencing. EBioMedicine. 95. 104747–104747. 12 indexed citations

Milligan, Scott, et al.. (2021). Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD. Hepatology Communications. 6(4). 765–779. 58 indexed citations

Corey, Kathleen E., Rebecca Pitts, Michelle Lai, et al.. (2021). ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. Journal of Hepatology. 76(1). 25–33. 48 indexed citations

Tiwari‐Heckler, Shilpa, Eric U. Yee, Jiwoon Park, et al.. (2021). Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease. Cell Reports. 37(4). 109897–109897. 7 indexed citations

An, Ping, Linlin Wei, Shuangshuang Zhao, et al.. (2020). Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nature Communications. 11(1). 2362–2362. 228 indexed citations breakdown →

10.

Danford, Christopher J., Jennifer Y. Lee, Ian A. Strohbehn, Kathleen E. Corey, & Michelle Lai. (2020). Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record. Digestive Diseases and Sciences. 66(5). 1452–1460. 6 indexed citations

11.

Sandhu, Bynvant, Stephanie Tran, Eva Csizmadia, et al.. (2019). Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity. JHEP Reports. 1(3). 199–202. 6 indexed citations

12.

Loomba, Rohit, Zeid Kayali, Mazen Noureddin, et al.. (2018). GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 155(5). 1463–1473.e6. 257 indexed citations breakdown →

13.

Tapper, Elliot B., Tracy Challies, Imad Nasser, Nezam H. Afdhal, & Michelle Lai. (2016). The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 111(5). 677–684. 110 indexed citations

14.

Tapper, Elliot B., Daniel Finkelstein, Murray A. Mittleman, et al.. (2015). A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 14(5). 753–759. 109 indexed citations

15.

Jiang, Z. Gordon, Ian H. de Boer, Rachel H. Mackey, et al.. (2015). Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study. Metabolism. 65(3). 92–99. 21 indexed citations

16.

Tapper, Elliot B., Neil Sengupta, M. G. Myriam Hunink, Nezam H. Afdhal, & Michelle Lai. (2015). Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography. The American Journal of Gastroenterology. 110(9). 1298–1304. 63 indexed citations

17.

Lai, Michelle & Nezam H. Afdhal. (2012). Clinical utility of interleukin-28B testing in patients with genotype 1. Hepatology. 56(1). 367–372. 12 indexed citations

18.

Kornek, Miroslaw, Michael C. Lynch, Shruti H. Mehta, et al.. (2012). Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis. Gastroenterology. 143(2). 448–458. 164 indexed citations

19.

Zhang, Ke, Wanlong Ma, Hairong Li, et al.. (2010). Ubiquitin‐proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. Journal of Gastroenterology and Hepatology. 26(4). 751–758. 13 indexed citations

20.

Brown, Robert S., Mark W. Russo, Michelle Lai, et al.. (2003). A Survey of Liver Transplantation from Living Adult Donors in the United States. New England Journal of Medicine. 348(9). 818–825. 360 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact